illumina hrd：Press Release
Press Release
2023年3月2日—TSO500HRDenablesresearcherstounlockdeeperinsightsaboutthetumorgenomebyidentifyinggeneticmutationsusedintheevaluationofHRD.。其他文章還包含有：「HomologousRecombinationDeficiency(HRD)Testingin...」、「IlluminaandMyriadGeneticsexpandpartnershipto...」、「TruSightOncology500Assay」、「TruSightOncology500High」、「TruSightOncology500HRD」、「TruSightOncology500HRDDataSheet」、「TruSig...
查看更多 離開網站
Homologous Recombination Deficiency (HRD) Testing in ...
https://www.illumina.com
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even ...
Illumina and Myriad Genetics expand partnership to ...
https://www.illumina.com
Illumina and Myriad today announced the expansion of a strategic partnership to broaden access to and. Expanding access to HRD research test.
TruSight Oncology 500 Assay
https://www.illumina.com
TruSight Oncology 500 HRD* is an optional add-on kit to TruSight Oncology 500 and enables detection of homologous recombination deficiency (HRD) through ...
TruSight Oncology 500 High
https://www.illumina.com
TruSight Oncology 500 HRD** kit content includes coverage of ~25,000 SNP's to assess homologous recombination deficiency through a comprehensive genomic ...
TruSight Oncology 500 HRD
https://www.illumina.com
TruSight Oncology 500 HRD is an NGS-based research assay that harnesses the power of proven Illumina NGS technology and the Myriad Genetics GIS algorithm to.
TruSight Oncology 500 HRD Data Sheet
https://www.illumina.com
TruSight Oncology 500 Portfolio
https://www.illumina.com
The portfolio is designed to identify relevant biomarkers in guidelines and clinical research, such as TMB, MSI and HRD. TruSight Oncology 500 Assay. Now with ...